Avanos Medical (AVNS) Treasury Shares (2015 - 2026)

Avanos Medical's Treasury Shares history runs 12 years deep, the most recent figure standing at $103.6 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 2.37% year-over-year to $103.6 million; the TTM figure through Mar 2026 stood at $103.6 million (up 2.37% YoY), while the FY2025 annual figure was $102.3 million, up 3.33% from the prior year.
• Treasury Shares came in at $103.6 million for Q1 2026 at Avanos Medical, up from $102.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.7 million in Q4 2024 to a low of $342680.0 in Q1 2024.
• A 5-year average of $1.1 million and a median of $911433.0 in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares jumped 538.46% in 2022 and climbed 2.37% in 2026, its largest moves.
• Avanos Medical's Treasury Shares stood at $66.8 million in 2022, then grew by 28.59% to $85.9 million in 2023, then advanced by 15.25% to $99.0 million in 2024, then gained by 3.33% to $102.3 million in 2025, then grew by 1.27% to $103.6 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $103.6 million, $102.3 million, and $102.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison